Generic Medicine

Shop Glycomet - GP 1 Online

Pack Size/Qty Price Unit Price  
90 Tablet/s $35.00 $0.40

Add to Cart

60 Tablet/s $25.00 $0.42

Add to Cart

30 Tablet/s $13.50 $0.45

Add to Cart

Generic Name : Metformin + Glimepiride

Brand Name : Glycomet GP 1

Manufacturer Name : US Vitamin

Product Code : CRX 229

Delivery Days : 10 to 15 working days

Packaging : Tablet/s (Blister Packing)

Prescribed For : Type 2 Diabetes Mellitus


Glycomet-GP 1


Glycomet-GP 1 is a medication that falls under the category of oral antidiabetic drugs. It is specifically designed to manage and control blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. This pharmaceutical compound is a combination of two active ingredients: Metformin and Glimepiride. The synergistic action of these components aims to address different aspects of glucose regulation within the body.

Metformin, the first component of Glycomet-GP 1, belongs to the biguanide class of antidiabetic drugs. It is considered a first-line treatment for type 2 diabetes and is widely prescribed due to its efficacy and safety profile. Metformin primarily works by reducing glucose production in the liver and enhancing the body's sensitivity to insulin, a hormone that plays a crucial role in regulating blood sugar levels. By improving insulin sensitivity, Metformin helps cells in the body absorb glucose more effectively, thereby reducing elevated blood glucose levels.

One notable aspect of Metformin is its unique mechanism of action, which does not involve increasing insulin secretion from the pancreas. This makes it particularly advantageous for individuals with type 2 diabetes, where the pancreas often produces insulin but the body's cells are resistant to its effects. Metformin's ability to target insulin resistance is a key factor in its success as a therapeutic agent for diabetes.

The second component, Glimepiride, is a sulfonylurea derivative. Sulfonylureas stimulate the pancreas to release more insulin, which is especially beneficial for individuals whose insulin secretion is insufficient to meet the body's demands. Glimepiride helps lower blood sugar levels by promoting insulin release from the beta cells in the pancreas. This dual-action approach, combining Metformin and Glimepiride, allows Glycomet-GP 1 to address both insulin resistance and insufficient insulin production, making it a comprehensive treatment option for type 2 diabetes.

Glycomet-GP 1 is typically prescribed as an oral medication, usually taken with meals to optimize its absorption and effectiveness. The dosage may vary depending on individual health factors, the severity of diabetes, and the response to the medication. Regular monitoring of blood glucose levels is crucial to ensure that the prescribed dosage is adequate and adjustments can be made as needed.

It is important for individuals taking Glycomet-GP 1 to adhere to their healthcare provider's recommendations and attend regular check-ups. Monitoring for side effects and assessing the overall effectiveness of the medication are essential components of diabetes management. Common side effects may include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, but these often subside as the body adjusts to the medication.

As with any medication, Glycomet-GP 1 is not without potential risks. It may not be suitable for individuals with certain medical conditions, such as severe kidney impairment or liver disease. Additionally, precautions should be taken when using Glycomet-GP 1 in elderly individuals or those with a history of hypoglycemia.

The comprehensive approach of Glycomet-GP 1 makes it a valuable tool in the management of type 2 diabetes. However, it is not a standalone solution. Lifestyle modifications, including a balanced diet, regular physical activity, and weight management, play crucial roles in diabetes management. Healthcare providers often emphasize the importance of a holistic approach to diabetes care, combining medication with lifestyle changes for optimal outcomes.

In conclusion, Glycomet-GP 1 is a combination medication that effectively addresses different facets of type 2 diabetes management. Through the synergistic action of Metformin and Glimepiride, it helps improve insulin sensitivity, reduce glucose production, and stimulate insulin release. As part of a comprehensive treatment plan, Glycomet-GP 1 contributes to the overall well-being of individuals with type 2 diabetes by helping them achieve and maintain better control of their blood sugar levels. Regular communication with healthcare providers and adherence to prescribed regimens are key elements in successfully managing diabetes with Glycomet-GP 1.


No details found!

Side Effect

No details found!


No details found!


No details found!


No details found!


No Review Found!

Post Your Comments